CIK 0001668243 · Non-accelerated filer<br>Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 9 770 7601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Financial Officer sold 2,202 shares at $36.69 ($80,791)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 871 shares at $42.92 ($37,383)
- 4 Open-market sale General Counsel sold 1,519 shares at $42.54 ($64,618)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 60,677 shares at $47.05 ($2,854,853)
- 144 Insider Sale of Securities
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $40.00 ($400,000)
- 144 Insider Sale of Securities
Page 1 of 30 · 584 filings